{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,10]],"date-time":"2026-11-10T16:46:23Z","timestamp":1794329183088,"version":"4.9.0"},"reference-count":277,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T00:00:00Z","timestamp":1785369600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:p>Multiple sclerosis is a chronic immune mediated disease in which current disease modifying therapies reduce inflammatory relapses but incompletely address neurodegeneration and remyelination. Natural flavonoids are pleiotropic polyphenols that can modulate immune and glial signaling, oxidative stress, and mitochondrial function. This review synthesizes evidence from experimental models and human studies on flavonoids relevant to multiple sclerosis, emphasizing mechanisms involving NF-\u03baB, Nrf2, inflammasome signaling, and microglia and macrophage polarization that shape oligodendrocyte precursor cell differentiation and remyelination permissiveness. We highlight structure activity features, metabolism and glycosylation that govern exposure, and discuss translational barriers including low and variable bioavailability, limited blood brain barrier penetration, standardization, and potential interactions with approved therapies. Emerging enabling strategies are reviewed, including lipid and polymeric nanocarriers, stimuli responsive delivery, systems biology and multi omics target discovery, network pharmacology for multi target prioritization, microbiome informed approaches, and synthetic biology for scalable production and derivative optimization. Overall, preclinical studies consistently support anti-inflammatory and neuroprotective effects, while clinical evidence remains early and mixed, underscoring the need for well powered trials with pharmacokinetic and pharmacodynamic endpoints.<\/jats:p>","DOI":"10.3389\/fimmu.2026.1888423","type":"journal-article","created":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T09:01:27Z","timestamp":1785402087000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":1,"title":["Natural flavonoids in multiple sclerosis: molecular insights and emerging therapeutic strategies"],"prefix":"10.3389","volume":"17","author":[{"given":"Abuyaseer","family":"Abusaliya","sequence":"first","affiliation":[{"name":"Department of Medical Microbiology and Immunology, College of Medicine and Health Sciences, United Arab Emirates University","place":["Abu Dhabi, United Arab Emirates"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mariam","family":"Al Shamsi","sequence":"additional","affiliation":[{"name":"Department of Medical Microbiology and Immunology, College of Medicine and Health Sciences, United Arab Emirates University","place":["Abu Dhabi, United Arab Emirates"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiba","family":"Orsud","sequence":"additional","affiliation":[{"name":"Department of Medical Microbiology and Immunology, College of Medicine and Health Sciences, United Arab Emirates University","place":["Abu Dhabi, United Arab Emirates"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zakeya","family":"Al Rasbi","sequence":"additional","affiliation":[{"name":"Department of Medical Microbiology and Immunology, College of Medicine and Health Sciences, United Arab Emirates University","place":["Abu Dhabi, United Arab Emirates"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sumaya","family":"Zoughbor","sequence":"additional","affiliation":[{"name":"Department of Medical Microbiology and Immunology, College of Medicine and Health Sciences, United Arab Emirates University","place":["Abu Dhabi, United Arab Emirates"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nura","family":"Joher","sequence":"additional","affiliation":[{"name":"College of Dentistry, Ajman University","place":["Ajman, United Arab Emirates"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,7,30]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"21","DOI":"10.21608\/jpsdm.2024.257173.1006","article-title":"Advances in understanding and treating multiple sclerosis: A comprehensive review","volume":"1","author":"Mohamed","year":"2024","journal-title":"J Pharm Sci Drug Manufacturing-Misr Univ For Sci Technol"},{"key":"B2","article-title":"Multiple sclerosis: I. Symptomatology and etiology","volume":"4","author":"Fymat","year":"2023","journal-title":"J Neurol Psychol Res"},{"key":"B3","doi-asserted-by":"crossref","DOI":"10.3109\/9780203212974","volume-title":"Multiple Sclerosis: Current Status and Strategies for the Future","author":"Johnston","year":"2001"},{"key":"B4","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1016\/j.autrev.2011.05.012","article-title":"Autoimmune disorders affecting both the central and peripheral nervous system","volume":"11","author":"Kamm","year":"2012","journal-title":"Autoimmun Rev"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2021.107562","article-title":"Flavonoids, the compounds with anti-inflammatory and immunomodulatory properties, as promising tools in multiple sclerosis (MS) therapy: A systematic review of preclinical evidence","volume":"95","author":"Bayat","year":"2021","journal-title":"Int Immunopharmacol"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.3390\/nu16172996","article-title":"Potential application of plant-derived compounds in multiple sclerosis management","volume":"16","author":"Woodfin","year":"2024","journal-title":"Nutrients"},{"key":"B7","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1007\/s12640-016-9600-1","article-title":"Impact of plant-derived flavonoids on neurodegenerative diseases","volume":"30","author":"Costa","year":"2016","journal-title":"Neurotoxic Res"},{"key":"B8","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1055\/s-0036-1579739","article-title":"Immunology of multiple sclerosis","volume":"23","author":"Sospedra","year":"2005","journal-title":"Annu Rev Immunol"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1007\/978-0-387-36003-4_13","article-title":"Pathogenic CD8+ T cells in multiple sclerosis","volume":"66","author":"Friese","year":"2009","journal-title":"Ann Neurol"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1038\/nm1651","article-title":"Human TH17 lymphocytes promote blood-brain barrier disruption and central nervous system inflammation","volume":"13","author":"Kebir","year":"2007","journal-title":"Nat Med"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1038\/nm0502-500","article-title":"Gene-microarray analysis of multiple sclerosis lesions yields new targets validated in autoimmune encephalomyelitis","volume":"8","author":"Lock","year":"2002","journal-title":"Nat Med"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1038\/ni.1716","article-title":"C-C chemokine receptor 6\u2013regulated entry of TH-17 cells into the CNS through the choroid plexus is required for the initiation of EAE","volume":"10","author":"Reboldi","year":"2009","journal-title":"Nat Immunol"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.171.1.368","article-title":"Vulnerability of human neurons to T cell-mediated cytotoxicity","volume":"61","author":"Giuliani","year":"2003","journal-title":"Neurology"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20031579","article-title":"Loss of functional suppression by CD4+CD25+ regulatory T cells in patients with multiple sclerosis","volume":"199","author":"Viglietta","year":"2004","journal-title":"J Exp Med"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1002\/eji.200526065","article-title":"Reduced suppressive effect of CD4+CD25high regulatory T cells on the T cell immune response against myelin oligodendrocyte glycoprotein in patients with multiple sclerosis","volume":"35","author":"Haas","year":"2005","journal-title":"Eur J Immunol"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.178.10.6092","article-title":"Distinct effector cytokine profiles of memory and naive human B cell subsets and implication in multiple sclerosis","volume":"178","author":"Duddy","year":"2007","journal-title":"J Immunol"},{"key":"B17","doi-asserted-by":"publisher","first-page":"310ra166","DOI":"10.1126\/scitranslmed.aab4176","article-title":"Proinflammatory GM-CSF\u2013producing B cells in multiple sclerosis and B cell depletion therapy","volume":"7","author":"Li","year":"2015","journal-title":"Sci Transl Med"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1016\/s1474-4422(17)30470-2","article-title":"Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria","volume":"17","author":"Thompson","year":"2018","journal-title":"Lancet Neurol"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1038\/nrn3722","article-title":"Microglia and brain macrophages in the molecular age: From origin to neuropsychiatric disease","volume":"8","author":"Prinz","year":"2017","journal-title":"Nat Rev Neurosci"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1038\/nn.3469","article-title":"M2 microglia and macrophages drive oligodendrocyte differentiation during CNS remyelination","volume":"16","author":"Miron","year":"2013","journal-title":"Nat Neurosci"},{"key":"B21","article-title":"Neuroprotection and neurodegeneration in multiple sclerosis","volume":"9","author":"Voskuhl","year":"2019","journal-title":"Cold Spring Harbor Perspect Med"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1038\/nrn3898","article-title":"Astrocyte barriers to neurotoxic inflammation","volume":"16","author":"Sofroniew","year":"2015","journal-title":"Nat Rev Neurosci"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1038\/nature14432","article-title":"Structural and functional features of central nervous system lymphatic vessels","volume":"523","author":"Louveau","year":"2015","journal-title":"Nature"},{"key":"B24","article-title":"Frequency of CD56+ cells in MS patients treated with interferon-\u03b2","volume":"41","author":"Maimone","year":"1991","journal-title":"Neurology"},{"key":"B25","article-title":"NF-\u03baB in the CNS: A paradigm for inflammation-induced neurodegeneration","volume":"20","author":"Nair","year":"2008","journal-title":"Curr Opin Immunol"},{"key":"B26","first-page":"3546","article-title":"The role of STAT3 in CNS autoimmunity","volume":"22","author":"Tsimpoulis","year":"2021","journal-title":"Int J Mol Sci"},{"key":"B27","article-title":"Functional analysis of EGFR signaling in neural stem\/progenitor cells","volume":"27","author":"Tyler","year":"2009","journal-title":"Stem Cells"},{"key":"B28","article-title":"Interferon-\u03b2 therapy against EAE is mediated by suppression of inflammation and apoptosis via IFN-\u03b2\/BDNF\/Akt signaling","volume":"5","author":"Inoue","year":"2014","journal-title":"Cell Death Dis"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1111\/bpa.12477","article-title":"Inflammasome activation in multiple sclerosis and experimental autoimmune encephalomyelitis (EAE)","volume":"27","author":"Barclay","year":"2017","journal-title":"Brain Pathol"},{"key":"B30","article-title":"How neuroimmunology came of age","volume":"9","author":"Ransohoff","year":"2009","journal-title":"Nat Rev Immunol"},{"key":"B31","article-title":"The advent of interferon beta therapy in multiple sclerosis: A historical perspective","volume":"248","author":"Trojano","year":"2001","journal-title":"J Neurol"},{"key":"B32","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.autrev.2012.09.005","article-title":"The mechanism of action of glatiramer acetate in multiple sclerosis and beyond","volume":"11","author":"Aharoni","year":"2014","journal-title":"Cell Mol Immunol"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.45.7.1268","article-title":"Copolymer 1 reduces relapse rate and improves disability in relapsing\u2010remitting multiple sclerosis: Results of a phase III multicenter, double\u2010blind, placebo\u2010controlled trial","volume":"45","author":"Johnson","year":"1995","journal-title":"Neurology"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1001\/archinte.162.19.2161","article-title":"Immunomodulatory agents for the treatment of relapsing multiple sclerosis: A systematic review","volume":"162","author":"Galetta","year":"2002","journal-title":"Arch Internal Med"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1056\/nejmoa1601277","article-title":"Ocrelizumab versus interferon beta-1a in relapsing multiple sclerosis","volume":"376","author":"Hauser","year":"2017","journal-title":"N Engl J Med"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0000000000000125","article-title":"Safety and efficacy of ofatumumab in relapsing multiple sclerosis: A phase 2 study","volume":"93","author":"Montalban","year":"2019","journal-title":"Neurology"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.4274\/npa.y6426","article-title":"Alemtuzumab vs. interferon beta-1a in early multiple sclerosis","volume":"359","author":"Coles","year":"2008","journal-title":"N Engl J Med"},{"key":"B38","article-title":"Effect of oral cladribine on walking speed in patients with relapsing-remitting multiple sclerosis: Post-hoc analysis of the CLARITY study","volume":"25","author":"Comi","year":"2019","journal-title":"Multiple Sclerosis J"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1097\/wnf.0b013e3181cbf825","article-title":"Mechanism of action of oral fingolimod (FTY720) in multiple sclerosis","volume":"32","author":"Chun","year":"2010","journal-title":"Clin Ther"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1016\/s1474-4422(16)00018-1","article-title":"Safety and efficacy of the selective sphingosine 1-phosphate receptor modulator ozanimod in relapsing multiple sclerosis (RADIANCE): A randomised, double-blind, phase 2 trial","volume":"16","author":"Cohen","year":"2017","journal-title":"Lancet Neurol"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1016\/s0140-6736(18)30475-6","article-title":"Siponimod versus placebo in secondary progressive multiple sclerosis (EXPAND): A double-blind, randomised, phase 3 study","volume":"391","author":"Kappos","year":"2018","journal-title":"Lancet"},{"key":"B42","doi-asserted-by":"publisher","first-page":"899","DOI":"10.1056\/nejmoa044397","article-title":"A randomized, placebo-controlled trial of natalizumab for relapsing multiple sclerosis","volume":"354","author":"Polman","year":"2006","journal-title":"N Engl J Med"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.3390\/antiox9070630","article-title":"Antioxidant and anti-inflammatory effect of Nrf2 inducer dimethyl fumarate in neurodegenerative diseases","volume":"9","author":"Scuderi","year":"2020","journal-title":"Antioxidants"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.1056\/nejmoa1114287","article-title":"Placebo-controlled phase 3 study of oral BG-12 for relapsing multiple sclerosis","volume":"367","author":"Gold","year":"2012","journal-title":"N Engl J Med"},{"key":"B45","doi-asserted-by":"publisher","first-page":"2055217315596994","DOI":"10.1177\/1352458514559299","article-title":"Dimethyl fumarate associated lymphopenia in clinical practice","volume":"1","author":"Longbrake","year":"2015","journal-title":"Multiple Sclerosis Journal: Experimental Trans Clin"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.1177\/1756286421993999","article-title":"Improved gastrointestinal profile with diroximel fumarate is associated with a positive impact on quality of life compared with dimethyl fumarate: Results from the randomized, double-blind, phase III EVOLVE-MS-2 study","volume":"14","author":"Wundes","year":"2021","journal-title":"Ther Adv Neurological Disord"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(98)03334-0","article-title":"Randomised double blind placebo controlled study of interferon beta 1a in relapsing remitting multiple sclerosis","volume":"352","year":"1998","journal-title":"Lancet"},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.1007\/bf00873695","article-title":"A review of the clinical efficacy profile of copolymer 1: New US phase III trial data","volume":"243","author":"Johnson","year":"1996","journal-title":"J Neurol"},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1107829","article-title":"Risk of natalizumab associated progressive multifocal leukoencephalopathy","volume":"366","author":"Bloomgren","year":"2012","journal-title":"N Engl J Med"},{"key":"B50","article-title":"Teriflunomide inhibits T cell proliferation by blocking the mitochondrial pyrimidine biosynthesis pathway","volume":"184","author":"Jones","year":"2010","journal-title":"J Immunol"},{"key":"B51","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1136\/jnnp.2006.091033","article-title":"Early mitoxantrone induced cardiotoxicity in secondary progressive multiple sclerosis","volume":"78","author":"Paul","year":"2007","journal-title":"J Neurology Neurosurgery Psychiatry"},{"key":"B52","doi-asserted-by":"publisher","DOI":"10.4324\/9781003547372-26","article-title":"Evidence report: The efficacy and safety of mitoxantrone (Novantrone) in the treatment of multiple sclerosis: Report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology","volume":"74","author":"Marriott","year":"2010","journal-title":"Neurology"},{"key":"B53","doi-asserted-by":"publisher","DOI":"10.1001\/jamaneurol.2022.5332","article-title":"Targeting B cells and microglia in multiple sclerosis with Bruton tyrosine kinase inhibitors: A review","volume":"80","author":"Dybowski","year":"2023","journal-title":"JAMA Neurol"},{"key":"B54","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2018.18743","article-title":"Effect of nonmyeloablative hematopoietic stem cell transplantation vs continued disease modifying therapy on disease progression in patients with relapsing remitting multiple sclerosis: A randomized clinical trial","volume":"321","author":"Burt","year":"2019","journal-title":"JAMA"},{"key":"B55","doi-asserted-by":"publisher","DOI":"10.1001\/jamaneurol.2016.5867","article-title":"Long term outcomes after autologous hematopoietic stem cell transplantation for multiple sclerosis","volume":"74","author":"Muraro","year":"2017","journal-title":"JAMA Neurol"},{"key":"B56","doi-asserted-by":"publisher","DOI":"10.1146\/annurev.neuro.30.051606.094313","article-title":"Multiple sclerosis: an immune or neurodegenerative disorder","volume":"31","author":"Trapp","year":"2008","journal-title":"Annu Rev Neurosci"},{"key":"B57","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.pneurobio.2010.09.005","article-title":"Mechanisms of neuronal dysfunction and degeneration in multiple sclerosis","volume":"93","author":"Dutta","year":"2011","journal-title":"Prog Neurobiol"},{"key":"B58","doi-asserted-by":"publisher","DOI":"10.1177\/1756285616628766","article-title":"Fingolimod in the treatment of relapsing\u2013remitting multiple sclerosis: long-term experience and an update on the clinical evidence","volume":"9","author":"Khatri","year":"2016","journal-title":"Ther Adv Neurological Disord"},{"key":"B59","doi-asserted-by":"publisher","DOI":"10.2174\/1389557511313030009","article-title":"Phenolic compounds as antioxidants: carbonic anhydrase isoenzymes inhibitors","volume":"13","author":"Gulcin","year":"2013","journal-title":"Mini-Rev Med Chem"},{"key":"B60","doi-asserted-by":"publisher","DOI":"10.21767\/1791-809x.1000596","article-title":"Challenges of extraction techniques of natural antioxidants and their potential application opportunities as anti-cancer agents","volume":"12","author":"Elnour","year":"2018","journal-title":"Health Sci J"},{"key":"B61","doi-asserted-by":"publisher","first-page":"586","DOI":"10.1002\/anie.201000044","article-title":"Plant polyphenols: chemical properties, biological activities, and synthesis","volume":"50","author":"Quideau","year":"2011","journal-title":"Angew Chem Int Ed"},{"key":"B62","doi-asserted-by":"publisher","DOI":"10.3390\/antiox9111035","article-title":"Flavonoids as a natural enhancer of neuroplasticity\u2014An overview of the mechanism of neurorestorative action","volume":"9","author":"Cichon","year":"2020","journal-title":"Antioxidants"},{"key":"B63","doi-asserted-by":"publisher","DOI":"10.3390\/ijms25158250","article-title":"Interactions between dietary antioxidants, dietary fiber and the gut microbiome: their putative role in inflammation and cancer","volume":"25","author":"Munteanu","year":"2024","journal-title":"Int J Mol Sci"},{"key":"B64","doi-asserted-by":"publisher","first-page":"34","DOI":"10.14218\/jerp.2023.00050","article-title":"Exploring the potential of dietary phytochemicals in cancer prevention: A comprehensive review","volume":"9","author":"Rathee","year":"2024","journal-title":"J Exploratory Res Pharmacol"},{"key":"B65","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1007\/978-981-97-4600-2_11","article-title":"Role of flavonoids as ethnomedicine for the treatment of complex neurodegenerative diseases","volume-title":"Traditional Resources and Tools for Modern Drug Discovery: Ethnomedicine and Pharmacology","author":"Das","year":"2024"},{"key":"B66","doi-asserted-by":"publisher","first-page":"42","DOI":"10.3892\/mi.2023.102","article-title":"Unleashing nature's potential and limitations: Exploring molecular targeted pathways and safe alternatives for the treatment of multiple sclerosis","volume":"3","author":"Fathallah","year":"2023","journal-title":"Med Int"},{"key":"B67","doi-asserted-by":"publisher","DOI":"10.1016\/j.heliyon.2023.e21741","article-title":"Quercetin as a possible complementary therapy in multiple sclerosis: Anti-oxidative, anti-inflammatory and remyelination potential properties","volume":"9","author":"Javanbakht","year":"2023","journal-title":"Heliyon"},{"key":"B68","doi-asserted-by":"publisher","DOI":"10.2174\/1389450118666161108124414","article-title":"Recent updates in imperative natural compounds for healthy brain and nerve function: a systematic review of implications for multiple sclerosis","volume":"18","author":"Sanadgol","year":"2017","journal-title":"Curr Drug Targets"},{"key":"B69","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1007\/s13273-021-00178-x","article-title":"Glycosidic flavonoids and their potential applications in cancer research: A review","volume":"18","author":"Abusaliya","year":"2022","journal-title":"Mol Cell Toxicol"},{"key":"B70","doi-asserted-by":"publisher","DOI":"10.1023\/b:joci.0000040925.55682.a5","article-title":"Quercetin, a flavonoid phytoestrogen, ameliorates experimental allergic encephalomyelitis by blocking IL-12 signaling through JAK-STAT pathway in T lymphocyte","volume":"24","author":"Muthian","year":"2004","journal-title":"J ClinImmunol"},{"key":"B71","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0025456","article-title":"Neuroprotective effect of combination therapy of glatiramer acetate and epigallocatechin 3 gallate in neuroinflammation","volume":"6","author":"Herges","year":"2011","journal-title":"PloS One"},{"key":"B72","doi-asserted-by":"publisher","DOI":"10.3390\/nu16162723","article-title":"The effects of epigallocatechin-3-gallate nutritional supplementation in the management of multiple sclerosis: A systematic review of clinical trials","volume":"16","author":"Schuldesz","year":"2024","journal-title":"Nutrients"},{"key":"B73","doi-asserted-by":"publisher","DOI":"10.1007\/s11064-015-1571-8","article-title":"Hesperidin, a citrus flavonoid, has ameliorative effects against experimental autoimmune encephalomyelitis (EAE) in a C57BL\/6J mouse model","volume":"40","author":"Ciftci","year":"2015","journal-title":"Neurochem Res"},{"key":"B74","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1186\/s12974-019-1514-4","article-title":"A co ultramicronized palmitoylethanolamide\/luteolin composite mitigates clinical score and disease relevant molecular markers in a mouse model of experimental autoimmune encephalomyelitis","volume":"16","author":"Contarini","year":"2019","journal-title":"J Neuroinflamm"},{"key":"B75","doi-asserted-by":"publisher","DOI":"10.1007\/s10787-024-01442-x","article-title":"Neuroprotective effects of rutin against cuprizone-induced multiple sclerosis in mice","volume":"32","author":"Nicola","year":"2024","journal-title":"Inflammopharmacology"},{"key":"B76","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbi.2015.11.002","article-title":"The natural dual cyclooxygenase and 5-lipoxygenase inhibitor flavocoxid is protective in experimental autoimmune encephalomyelitis through effects on Th1\/Th17 differentiation and macrophage\/microglia activation","volume":"110","author":"Kong","year":"2016","journal-title":"Neuropharmacology"},{"key":"B77","doi-asserted-by":"publisher","DOI":"10.1016\/j.brainresbull.2017.09.007","article-title":"The flavonoid baicalein attenuates cuprizone-induced demyelination via suppression of neuroinflammation","volume":"108","author":"Hashimoto","year":"2017","journal-title":"Neurochem Int"},{"key":"B78","doi-asserted-by":"publisher","DOI":"10.1016\/j.jnutbio.2023.109448","article-title":"Naringenin confers protection against experimental autoimmune encephalomyelitis through modulating the gut-brain axis: A multiomics analysis","volume":"122","author":"Liu","year":"2023","journal-title":"J Nutr Biochem"},{"key":"B79","doi-asserted-by":"publisher","DOI":"10.2174\/1381612826666201113094303","article-title":"Kolaviron: A biflavonoid with numerous health benefits","volume":"27","author":"Erukainure","year":"2021","journal-title":"Curr Pharm Des"},{"key":"B80","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2021.107715","article-title":"Significant immunomodulatory and hepatoprotective impacts of silymarin in MS patients: a double-blind placebo-controlled clinical trial","volume":"97","author":"Abbasirad","year":"2021","journal-title":"Int Immunopharmacol"},{"key":"B81","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2008.05.002","article-title":"Genistein down-modulates pro-inflammatory cytokines and reverses clinical signs of experimental autoimmune encephalomyelitis","volume":"82","author":"De Paula","year":"2008","journal-title":"Life Sci"},{"key":"B82","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijdevneu.2015.04.295","article-title":"Alleviation of experimental allergic encephalomyelitis in C57BL\/6 mice by soy daidzein","volume":"131","author":"Jahromi","year":"2014","journal-title":"Iranian J Allergy Asthma Immunol"},{"key":"B83","doi-asserted-by":"publisher","DOI":"10.1007\/s11481-015-9617-x","article-title":"Apigenin, a natural flavonoid, attenuates EAE severity through the modulation of dendritic cell and other immune cell functions","volume":"11","author":"Ginwala","year":"2016","journal-title":"J Neuroimmune Pharmacol"},{"key":"B84","doi-asserted-by":"publisher","first-page":"608","DOI":"10.1186\/s13287-025-04742-3","article-title":"Mesenchymal stem cells derived exosomes and kaempferol improve myelin repair via attenuating inflammation and oxidative stress in a cuprizone induced demyelination model","volume":"16","author":"Rabiei","year":"2025","journal-title":"Stem Cell Res Ther"},{"key":"B85","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1007\/s11481-025-10260-z","article-title":"Fisetin mitigates ferroptosis and promotes remyelination in a cuprizone model of multiple sclerosis","volume":"20","author":"El-Ashmawy","year":"2025","journal-title":"J Neuroimmune Pharmacol"},{"key":"B86","doi-asserted-by":"publisher","DOI":"10.1007\/s12035-023-03706-z","article-title":"Polyphenols targeting MAP kinase signaling pathway in neurological diseases: understanding molecular mechanisms and therapeutic targets","volume":"61","author":"Islam","year":"2024","journal-title":"Mol Neurobiol"},{"key":"B87","doi-asserted-by":"publisher","DOI":"10.3390\/cancers12082276","article-title":"Targeting multiple signaling pathways in cancer: The rutin therapeutic approach","volume":"12","author":"Nouri","year":"2020","journal-title":"Cancers"},{"key":"B88","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/9781394238071.ch1","article-title":"Exploring the therapeutic power of flavonoids on chronic disease: Unraveling the mechanisms of action especially by following MAPKs\/NF\u2010KB signaling pathways","volume-title":"Role of Flavonoids in Chronic Metabolic Diseases: From Bench to Clinic","author":"Ahmad","year":"2024"},{"key":"B89","doi-asserted-by":"publisher","DOI":"10.3390\/ijms222212455","article-title":"Targeting PI3K\/Akt\/mTOR pathway by different flavonoids: a cancer chemopreventive approach","volume":"22","author":"Zughaibi","year":"2021","journal-title":"Int J Mol Sci"},{"key":"B90","doi-asserted-by":"publisher","DOI":"10.1080\/10715760410001727858","article-title":"Pharmacokinetics and metabolism of dietary flavonoids in humans","volume":"38","author":"Manach","year":"2004","journal-title":"Free Radic Res"},{"key":"B91","doi-asserted-by":"publisher","DOI":"10.1093\/ajcn\/81.1.230s","article-title":"Bioavailability and bioefficacy of polyphenols in humans. I. Review of 97 bioavailability studies","volume":"81","author":"Manach","year":"2005","journal-title":"Am J Clin Nutr"},{"key":"B92","doi-asserted-by":"publisher","DOI":"10.1212\/nxi.0000000000000964","article-title":"Epigallocatechin gallate in progressive MS: A randomized, placebo controlled trial","volume":"8","author":"Rust","year":"2021","journal-title":"Neurology: Neuroimmunology Neuroinflamm"},{"key":"B93","doi-asserted-by":"publisher","DOI":"10.1212\/wnl.0b013e31826aac60","article-title":"Ginkgo biloba does not improve cognitive function in MS: A randomized placebo controlled trial","volume":"79","author":"Lovera","year":"2012","journal-title":"Neurology"},{"key":"B94","doi-asserted-by":"publisher","DOI":"10.1007\/s00401-009-0591-3","article-title":"The cuprizone animal model: New insights into an old story","volume":"118","author":"Kipp","year":"2009","journal-title":"Acta Neuropathol"},{"key":"B95","doi-asserted-by":"publisher","DOI":"10.1186\/s12950-021-00285-5","article-title":"Luteolin transforms the polarity of bone marrow-derived macrophages to regulate the cytokine storm","volume":"18","author":"Wang","year":"2021","journal-title":"J Inflammation"},{"key":"B96","doi-asserted-by":"publisher","DOI":"10.1038\/srep17407","article-title":"Therapeutic effect of baicalin on experimental autoimmune encephalomyelitis is mediated by SOCS3 regulatory pathway","volume":"5","author":"Zhang","year":"2015","journal-title":"Sci Rep"},{"key":"B97","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1038\/s41401-020-0411-9","article-title":"Baicalin prevents LPS-induced activation of TLR4\/NF-\u03baB p65 pathway and inflammation in mice via inhibiting the expression of CD14","volume":"42","author":"Fu","year":"2021","journal-title":"Acta Pharmacol Sin"},{"key":"B98","doi-asserted-by":"publisher","DOI":"10.1016\/j.freeradbiomed.2024.12.036","article-title":"Baicalein disrupts the KEAP1 NRF2 interaction to alleviate oxidative stress injury by inhibiting M1 macrophage polarization","volume":"227","author":"Chi","year":"2024","journal-title":"Free Radical Biol Med"},{"key":"B99","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2023.114222","article-title":"The benefits of hesperidin in central nervous system disorders, based on the neuroprotective effect","volume":"159","author":"Li","year":"2023","journal-title":"Biomedicine Pharmacotherapy"},{"key":"B100","doi-asserted-by":"publisher","DOI":"10.1007\/s11481-020-09933-8","article-title":"Apigenin modulates dendritic cell activities and curbs inflammation via RelB inhibition, reducing IL12, IL23 and IL17","volume":"16","author":"Ginwala","year":"2020","journal-title":"J Neuroimmune Pharmacol"},{"key":"B101","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/j.ebiom.2016.06.017","article-title":"Activation of PPAR\u03b3 by a natural flavonoid modulator, apigenin ameliorates obesity related inflammation via regulation of macrophage polarization","volume":"9","author":"Feng","year":"2016","journal-title":"EBioMedicine"},{"key":"B102","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/j.cbi.2017.07.004","article-title":"The flavonoid rutin modulates microglial\/macrophage activation to a CD150\/CD206 M2 phenotype","volume":"274","author":"da Silva","year":"2017","journal-title":"Chem Biol Interact"},{"key":"B103","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2024.113538","article-title":"Kaempferol improves depression like behaviors through shifting microglia polarization and suppressing NLRP3 via tilting the balance of PPAR\u03b3 and STAT1 signaling","volume":"143","author":"Su","year":"2024","journal-title":"Int Immunopharmacol"},{"key":"B104","doi-asserted-by":"publisher","DOI":"10.2174\/1389557519666190617150051","article-title":"The roles of flavonols\/flavonoids in neurodegeneration and neuroinflammation","volume":"20","author":"Calis","year":"2020","journal-title":"Mini-Rev Med Chem"},{"key":"B105","doi-asserted-by":"publisher","DOI":"10.1016\/j.foodchem.2022.132531","article-title":"Plant flavonoids: Classification, distribution, biosynthesis, and antioxidant activity","volume":"383","author":"Shen","year":"2022","journal-title":"Food Chem"},{"key":"B106","doi-asserted-by":"publisher","DOI":"10.3390\/molecules28134982","article-title":"A review of classification, biosynthesis, biological activities and potential applications of flavonoids","volume":"28","author":"Chen","year":"2023","journal-title":"Molecules"},{"key":"B107","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejmech.2014.07.013","article-title":"Flavones: An important scaffold for medicinal chemistry","volume":"84","author":"Singh","year":"2014","journal-title":"Eur J Med Chem"},{"key":"B108","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejmech.2017.09.001","article-title":"Anti-inflammatory effects of flavonoids in neurodegenerative disorders","volume":"153","author":"Spagnuolo","year":"2018","journal-title":"Eur J Med Chem"},{"key":"B109","doi-asserted-by":"publisher","DOI":"10.1080\/14786419.2010.482054","article-title":"Flavonoids: chemical properties and analytical methodologies of identification and quantitation in foods and plants","volume":"25","author":"Corradini","year":"2011","journal-title":"Nat Prod Res"},{"key":"B110","doi-asserted-by":"publisher","DOI":"10.3389\/fphys.2022.863860","article-title":"Dietary flavonoids as modulators of lipid metabolism in poultry","volume":"13","author":"Tan","year":"2022","journal-title":"Front Physiol"},{"key":"B111","doi-asserted-by":"crossref","DOI":"10.1201\/b11599","volume-title":"Chemistry of Natural Products: A Unified Approach","author":"Krishnaswamy","year":"2010"},{"key":"B112","first-page":"16","article-title":"Flavones (apigenin, luteolin, chrysin) and their importance for health","volume":"20","author":"\u00d6zcan","year":"2020","journal-title":"Mellifera"},{"key":"B113","doi-asserted-by":"publisher","DOI":"10.1021\/jf000892m","article-title":"Flavonoid (myricetin, quercetin, kaempferol, luteolin, and apigenin) content of edible tropical plants","volume":"49","author":"Miean","year":"2001","journal-title":"J Agric Food Chem"},{"key":"B114","doi-asserted-by":"publisher","DOI":"10.1080\/10408398.2023.2185201","article-title":"Glycosylation of flavonoids by sucrose-and starch-utilizing glycoside hydrolases: A practical approach to enhance glycodiversification","volume":"64","author":"Tian","year":"2024","journal-title":"Crit Rev Food Sci Nutr"},{"key":"B115","doi-asserted-by":"publisher","DOI":"10.1016\/j.bioteChadv.2014.04.006","article-title":"Advances in the biotechnological glycosylation of valuable flavonoids","volume":"32","author":"Xiao","year":"2014","journal-title":"Biotechnol Adv"},{"key":"B116","doi-asserted-by":"publisher","DOI":"10.1080\/10408398.2012.694497","article-title":"The occurrence, fate and biological activities of C-glycosyl flavonoids in the human diet","volume":"55","author":"Courts","year":"2015","journal-title":"Crit Rev Food Sci Nutr"},{"key":"B117","doi-asserted-by":"publisher","DOI":"10.1016\/s1521-6918(03)00107-0","article-title":"Intestinal absorption in health and disease\u2014sugars","volume":"17","author":"Wright","year":"2003","journal-title":"Best Pract Res Clin Gastroenterol"},{"key":"B118","doi-asserted-by":"publisher","DOI":"10.3390\/ijms22168370","article-title":"Reviewing the significance of blood\u2013brain barrier disruption in multiple sclerosis pathology and treatment","volume":"22","author":"Balasa","year":"2021","journal-title":"Int J Mol Sci"},{"key":"B119","doi-asserted-by":"publisher","first-page":"100235","DOI":"10.1016\/j.crbiot.2024.100235","article-title":"A new frontier in neuropharmacology: Recent progress in natural products research for blood\u2013brain barrier crossing","volume":"8","author":"Isabel","year":"2024","journal-title":"Curr Res Biotechnol"},{"key":"B120","doi-asserted-by":"publisher","DOI":"10.1007\/s10753-014-9995-x","article-title":"Flavonoids inhibit COX-1 and COX-2 enzymes and cytokine\/chemokine production in human whole blood","volume":"38","author":"Ribeiro","year":"2015","journal-title":"Inflammation"},{"key":"B121","doi-asserted-by":"publisher","DOI":"10.3390\/foods11060882","article-title":"Comparison of flavonoid O-glycoside, C-glycoside and their aglycones on antioxidant capacity and metabolism during in vitro digestion and in vivo","volume":"11","author":"Xie","year":"2022","journal-title":"Foods"},{"key":"B122","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbi.2016.01.005","article-title":"Adult oligodendrocyte precursor cells \u2013 multifaceted regulators of the CNS in health and disease","volume":"29","author":"Kotter","year":"2006","journal-title":"Trends Neurosci"},{"key":"B123","doi-asserted-by":"publisher","DOI":"10.1038\/nature21029","article-title":"Neurotoxic reactive astrocytes are induced by activated microglia","volume":"541","author":"Liddelow","year":"2017","journal-title":"Nature"},{"key":"B124","article-title":"Mechanisms of pathogenesis in multiple sclerosis: Recent insights from immunology and neuroimaging","volume":"7","author":"Agrawal","year":"2008","journal-title":"Lancet Neurol"},{"key":"B125","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1711233114","article-title":"Gut microbiota from multiple sclerosis patients enables spontaneous autoimmune encephalomyelitis in mice","volume":"114","author":"Berer","year":"2017","journal-title":"Proc Natl Acad Sci"},{"key":"B126","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1711235114","article-title":"Gut bacteria from multiple sclerosis patients modulate immune responses and demyelination in mice","volume":"114","author":"Cekanaviciute","year":"2017","journal-title":"Proc Natl Acad Sci"},{"key":"B127","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2012.03.014","article-title":"JAK and STAT signaling molecules in immunoregulation and immune-mediated disease","volume":"36","author":"O'Shea","year":"2012","journal-title":"Immunity"},{"key":"B128","article-title":"The role of nitric oxide in multiple sclerosis","volume":"12","author":"Minagar","year":"2006","journal-title":"Multiple Sclerosis J"},{"key":"B129","article-title":"PI3K\/Akt and mTOR pathway involvement in neural stem cell proliferation and differentiation","volume":"87","author":"Chen","year":"2009","journal-title":"J Neurosci Res"},{"key":"B130","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms12504","article-title":"Fenamate NSAIDs inhibit the NLRP3 inflammasome and protect against Alzheimer\u2019s disease in rodent models","volume":"7","author":"Daniels","year":"2016","journal-title":"Nat Commun"},{"key":"B131","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/awq386","article-title":"Fumaric acid esters exert neuroprotective effects in neuroinflammation via activation of the Nrf2 antioxidant pathway","volume":"134","author":"Linker","year":"2011","journal-title":"Brain"},{"key":"B132","doi-asserted-by":"publisher","DOI":"10.1038\/nn.3676","article-title":"Parallel states of pathological Wnt signaling in neonatal brain injury and colon cancer","volume":"17","author":"Fancy","year":"2014","journal-title":"Nat Neurosci"},{"key":"B133","doi-asserted-by":"publisher","DOI":"10.1002\/stem.624","article-title":"Wnt signaling promotes neuronal differentiation from mesenchymal stem cells through activation of TCF\/LEF transcription factors","volume":"27","author":"Ye","year":"2009","journal-title":"Stem Cells"},{"key":"B134","article-title":"Gray matter antigen-specific T cells in patients with MS","volume":"61","author":"Giuliani","year":"2003","journal-title":"Neurology"},{"key":"B135","doi-asserted-by":"publisher","DOI":"10.1097\/wco.0b013e3283533a25","article-title":"Mitochondrial changes within axons in multiple sclerosis","volume":"131","author":"Mahad","year":"2008","journal-title":"Brain"},{"key":"B136","article-title":"Epigenetic targets of flavonoids in the brain","volume":"85","author":"Deshpande","year":"2013","journal-title":"Biochem Pharmacol"},{"key":"B137","article-title":"Epigenetic regulation in autoimmune diseases: A therapeutic perspective","volume":"13","author":"Kim","year":"2014","journal-title":"Autoimmun Rev"},{"key":"B138","article-title":"Autophagy in multiple sclerosis: From pathogenesis to therapeutic opportunities","volume":"11","author":"Djelloul","year":"2015","journal-title":"Autophagy"},{"key":"B139","article-title":"Autophagic and apoptotic mechanisms cooperate to promote death of neurons in ex vivo spinal cord injury","volume":"4","author":"Liang","year":"2008","journal-title":"Autophagy"},{"key":"B140","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/121.8.1469","article-title":"Axonal damage correlates with disability in patients with relapsing-remitting multiple sclerosis","volume":"59","author":"Dutta","year":"2006","journal-title":"Ann Neurol"},{"key":"B141","article-title":"Microtubule stabilization as a therapeutic strategy in axonopathies","volume":"18","author":"Wu","year":"2012","journal-title":"Trends Mol Med"},{"key":"B142","doi-asserted-by":"publisher","DOI":"10.1002\/ptr.70097","article-title":"Pharmacological diversity of flavonoids and their clinical application prospects in neurological disorders","volume":"39","author":"Cheng","year":"2025","journal-title":"Phytother Res"},{"key":"B143","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.neuropharm.2012.06.025","article-title":"Epimedium flavonoids ameliorate experimental autoimmune encephalomyelitis in rats by modulating neuroinflammatory and neurotrophic responses","volume":"238","author":"Yin","year":"2012","journal-title":"Exp Neurol"},{"key":"B144","doi-asserted-by":"publisher","DOI":"10.1111\/sji.13106","article-title":"Immunomodulatory potential of flavonoids for the treatment of autoimmune diseases and tumour","volume":"95","author":"Han","year":"2022","journal-title":"Scand J Immunol"},{"key":"B145","doi-asserted-by":"publisher","DOI":"10.1155\/2018\/9324357","article-title":"The role of flavonoids in inhibiting Th17 responses in inflammatory arthritis","volume":"2018","author":"Kelepouri","year":"2018","journal-title":"J Immunol Res"},{"key":"B146","doi-asserted-by":"publisher","DOI":"10.1016\/j.fct.2020.111817","article-title":"Flavonoids targeting NRF2 in neurodegenerative disorders","volume":"406","author":"Khan","year":"2020","journal-title":"Toxicol Appl Pharmacol"},{"key":"B147","doi-asserted-by":"publisher","DOI":"10.3390\/ijms242417223","article-title":"Oxidative stress and the nuclear factor erythroid 2-related factor 2 (Nrf2) pathway in multiple sclerosis: Focus on certain exogenous and endogenous Nrf2 activators","volume":"24","author":"Tonev","year":"2023","journal-title":"Int J Mol Sci"},{"key":"B148","doi-asserted-by":"publisher","DOI":"10.2174\/1871524916666160226131842","article-title":"Epigenetics in multiple sclerosis: Molecular mechanisms and dietary intervention","volume":"17","author":"Rito","year":"2018","journal-title":"CNS Neurological Disord - Drug Targets"},{"key":"B149","doi-asserted-by":"publisher","DOI":"10.1007\/s12035-025-04868-8","article-title":"Epigenetic and mitochondrial metabolic dysfunction in multiple sclerosis: A review of herbal drug approaches and current clinical trials","volume":"62","author":"Ashwani","year":"2025","journal-title":"Mol Neurobiol"},{"key":"B150","doi-asserted-by":"publisher","DOI":"10.1007\/s43440-019-00019-8","article-title":"Myelin recovery and ameliorates behavioral deficits in the animal model of multiple sclerosis via adjustment of AMPK\/Nrf2\/mTOR signaling and maintenance of mitochondrial integrity","volume":"35","author":"Sanadgol","year":"2020","journal-title":"Metab Brain Dis"},{"key":"B151","doi-asserted-by":"publisher","DOI":"10.3389\/fnmol.2019.00314","article-title":"Inflammatory role of TLR-MyD88 signaling in multiple sclerosis","volume":"12","author":"Zheng","year":"2020","journal-title":"Front Mol Neurosci"},{"key":"B152","doi-asserted-by":"publisher","DOI":"10.1007\/s00011-023-01801-4","article-title":"Targeting MyD88: Therapeutic mechanisms and potential in inflammatory diseases","volume":"72","author":"Liu","year":"2023","journal-title":"Inflammation Res"},{"key":"B153","doi-asserted-by":"publisher","first-page":"105778","DOI":"10.1002\/ptr.6268","article-title":"Synergistic anti-inflammatory effects of quercetin and catechin via inhibiting activation of TLR4-MyD88-mediated NF-\u03baB and MAPK signaling pathways","volume":"75","author":"Li","year":"2019","journal-title":"Int Immunopharmacol"},{"key":"B154","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbrc.2012.08.096","article-title":"Green tea polyphenol epigallocatechin-3-gallate inhibits TLR4 signaling through the 67-kDa laminin receptor on LPS-stimulated dendritic cells","volume":"426","author":"Byun","year":"2012","journal-title":"Biochem Biophys Res Commun"},{"key":"B155","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1007\/s00011-018-1146-7","article-title":"Genistein modulates the expression of Toll-like receptors in experimental autoimmune encephalomyelitis","volume":"67","author":"Dias","year":"2018","journal-title":"Inflammation Res"},{"key":"B156","doi-asserted-by":"publisher","DOI":"10.1016\/j.cbi.2014.01.012","article-title":"Anti-inflammatory effects of genistein via suppression of the toll-like receptor 4-mediated signaling pathway in lipopolysaccharide-stimulated BV2 microglia","volume":"212","author":"Jeong","year":"2014","journal-title":"Chem Biol Interact"},{"key":"B157","doi-asserted-by":"publisher","DOI":"10.3164\/jcbn.20-178","article-title":"Nobiletin suppresses the development of experimental autoimmune encephalomyelitis mediated by modulation of T helper 17 cell differentiation","volume":"69","author":"Nakamoto","year":"2021","journal-title":"J Clin Biochem Nutr"},{"key":"B158","doi-asserted-by":"publisher","DOI":"10.1080\/08923973.2024.2360050","article-title":"Nobiletin derivative, 5-acetoxy-6, 7, 8, 3\u2019, 4\u2019-pentamethoxyflavone, inhibits neuroinflammation through the inhibition of TLR4\/MyD88\/MAPK signaling pathways and STAT3 in microglia","volume":"46","author":"Chuang","year":"2024","journal-title":"Immunopharmacol Immunotoxicol"},{"key":"B159","doi-asserted-by":"publisher","DOI":"10.1016\/j.jneuroim.2018.04.002","article-title":"Increased constitutive activation of NF kappa B p65 in peripheral blood cells of patients with progressive multiple sclerosis","volume":"320","author":"Yan","year":"2018","journal-title":"J Neuroimmunology"},{"key":"B160","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.00391","article-title":"Nuclear factor kappa B mediated inflammation in multiple sclerosis","volume":"11","author":"Liu","year":"2020","journal-title":"Front Immunol"},{"key":"B161","doi-asserted-by":"publisher","DOI":"10.3389\/fnmol.2016.00084","article-title":"NF kappa B pathways in the pathogenesis of multiple sclerosis and the therapeutic implications","volume":"9","author":"Leibowitz","year":"2016","journal-title":"Front Mol Neurosci"},{"key":"B162","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20110462","article-title":"The Th17 immune response is controlled by a Rel ROR gamma ROR gamma T transcriptional axis","volume":"208","author":"Ruan","year":"2011","journal-title":"J Exp Med"},{"key":"B163","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1204557109","article-title":"T cell receptor CARMA1 NF kappa B signaling controls Th17 differentiation","volume":"109","author":"Molinero","year":"2012","journal-title":"Proc Natl Acad Sci USA"},{"key":"B164","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.163.6.3474","article-title":"Curcumin blocks cytokine mediated NF kappa B activation and proinflammatory gene expression","volume":"163","author":"Jobin","year":"1999","journal-title":"J Immunol"},{"key":"B165","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2009.01.025","article-title":"Amelioration of experimental autoimmune encephalomyelitis by curcumin treatment is associated with reduced inflammatory cell infiltration in the spinal cord and improved clinical scores","volume":"9","author":"Xie","year":"2009","journal-title":"Int Immunopharmacol"},{"key":"B166","first-page":"1178932","article-title":"Baicalin facilitates remyelination and suppresses neuroinflammation in cuprizone demyelination and EAE models","volume":"14","author":"Jin","year":"2023","journal-title":"Front Immunol"},{"key":"B167","first-page":"87","article-title":"Neuroprotective effects of wogonin against inflammation and oxidative stress in experimental autoimmune encephalomyelitis","volume":"245","author":"Lee","year":"2012","journal-title":"J Neuroimmunology"},{"key":"B168","first-page":"104958","article-title":"Isoorientin enhances memory performance via upregulation of hippocampal BDNF through CREB phosphorylation","volume":"144","author":"Zhang","year":"2021","journal-title":"Neurochem Int"},{"key":"B169","first-page":"104482","article-title":"Scutellarin protects against demyelination and mitochondrial dysfunction in a cuprizone-induced mouse model","volume":"129","author":"Li","year":"2019","journal-title":"Neurochem Int"},{"key":"B170","first-page":"74","article-title":"Vitexin protects neurons against NMDA-induced excitotoxicity through inhibition of NMDAR signaling","volume":"146","author":"Wang","year":"2019","journal-title":"Neuropharmacology"},{"key":"B171","first-page":"19","article-title":"Luteolin improves cognitive function and increases hippocampal HSP70 expression in sleep-deprived mice","volume":"89","author":"Zhao","year":"2015","journal-title":"Neurochem Int"},{"key":"B172","first-page":"146574","article-title":"Baicalin protects blood\u2013brain barrier integrity and reduces BBB permeability through modulation of tight junction proteins and MMP-9 inhibition","volume":"1727","author":"Yang","year":"2020","journal-title":"Brain Res"},{"key":"B173","article-title":"Baicalin and kaempferol promote angiogenesis via activation of the VEGF\/VEGFR2 pathway in endothelial cells","volume":"48","author":"Chen","year":"2018","journal-title":"Phytomedicine"},{"key":"B174","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0079201","article-title":"Wogonin has multiple anti cancer effects by regulating c Myc SKP2 Fbw7\u03b1 and HDAC1 HDAC2 pathways and inducing apoptosis in human lung adenocarcinoma cell line A549","volume":"8","author":"Chen","year":"2013","journal-title":"PloS One"},{"key":"B175","doi-asserted-by":"publisher","DOI":"10.1007\/s12017-023-08747-0","article-title":"Potential of quercetin to protect cadmium induced cognitive deficits in rats by modulating NMDA receptor mediated downstream signaling and PI3K AKT Nrf2 ARE signaling pathways in hippocampus","volume":"25","author":"Srivastava","year":"2023","journal-title":"NeuroMol Med"},{"key":"B176","doi-asserted-by":"publisher","DOI":"10.2147\/dddt.s493779","article-title":"Quercetin improves hippocampal neurogenesis in depression by regulating the level of let 7e 5p in microglia exosomes","volume":"19","author":"Xie","year":"2025","journal-title":"Drug Des Dev Ther"},{"key":"B177","doi-asserted-by":"publisher","DOI":"10.1016\/s1474-4422(08)70259-x","article-title":"Cognitive impairment in multiple sclerosis","volume":"7","author":"Chiaravalloti","year":"2008","journal-title":"Lancet Neurol"},{"key":"B178","doi-asserted-by":"publisher","DOI":"10.1096\/fj.12-212118","article-title":"Identification of brain targeted bioactive dietary quercetin 3 O glucuronide as a novel intervention for Alzheimer\u2019s disease","volume":"27","author":"Ho","year":"2013","journal-title":"FASEB J"},{"key":"B179","doi-asserted-by":"publisher","first-page":"2650","DOI":"10.3389\/fimmu.2019.02650","article-title":"Isovitexin mediated regulation of microglial polarization in lipopolysaccharide induced neuroinflammation via activation of the CaMKK\u03b2\/AMPK PGC 1\u03b1 signaling axis","volume":"10","author":"Liu","year":"2019","journal-title":"Front Immunol"},{"key":"B180","doi-asserted-by":"publisher","DOI":"10.3389\/fncel.2018.00531","article-title":"Targeting MAPK pathways by naringenin modulates microglia M1\/M2 polarization in lipopolysaccharide stimulated cultures","volume":"12","author":"Zhang","year":"2018","journal-title":"Front Cell Neurosci"},{"key":"B181","doi-asserted-by":"publisher","DOI":"10.1111\/cns.13086","article-title":"Baicalin mitigates cognitive impairment and protects neurons from microglia mediated neuroinflammation via suppressing NLRP3 inflammasomes and TLR4\/NF \u03baB signaling pathway","volume":"25","author":"Jin","year":"2019","journal-title":"CNS Neurosci Ther"},{"key":"B182","doi-asserted-by":"publisher","DOI":"10.1016\/j.redox.2021.102010","article-title":"Quercetin hinders microglial activation to alleviate neurotoxicity via the interplay between NLRP3 inflammasome and mitophagy","volume":"44","author":"Han","year":"2021","journal-title":"Redox Biol"},{"key":"B183","doi-asserted-by":"publisher","DOI":"10.1007\/s00401-020-02193-z","article-title":"TREM2 activation on microglia promotes myelin debris clearance and remyelination in a model of multiple sclerosis","volume":"140","author":"Cignarella","year":"2020","journal-title":"Acta Neuropathol"},{"key":"B184","doi-asserted-by":"publisher","first-page":"17937","DOI":"10.18632\/oncotarget.24788","article-title":"Phytochemicals as modulators of M1 M2 macrophages in inflammation","volume":"9","author":"Saqib","year":"2018","journal-title":"Oncotarget"},{"key":"B185","first-page":"1432821","article-title":"Flavonoids mitigate oxidative stress and gut barrier dysfunction through modulation of superoxide dismutase activity and epithelial regeneration","volume":"16","author":"Kannan","year":"2025","journal-title":"Front Pharmacol"},{"key":"B186","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2023.115653","article-title":"Quercetin improves cerebral ischemia\/reperfusion injury by promoting microglia\/macrophages M2 polarization via regulating PI3K\/Akt\/NF \u03baB signaling pathway","volume":"168","author":"Li","year":"2023","journal-title":"Biomedicine Pharmacotherapy"},{"key":"B187","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1016\/j.nutres.2022.09.001","article-title":"Bioactive compounds modulating Toll like 4 receptor TLR4 mediated inflammation: pathways involved and future perspectives","volume":"107","author":"Coutinho-Wolino","year":"2022","journal-title":"Nutr Res"},{"key":"B188","doi-asserted-by":"publisher","DOI":"10.1016\/j.phymed.2023.154801","article-title":"Myricetin improves pathological changes in 3\u00d7 Tg AD mice by regulating the mitochondria NLRP3 inflammasome microglia channel by targeting P38 MAPK signaling pathway","volume":"115","author":"Liu","year":"2023","journal-title":"Phytomedicine"},{"key":"B189","doi-asserted-by":"publisher","DOI":"10.1007\/s12640-019-00102-1","article-title":"Cyanidin 3 O glucoside protects PC12 cells against neuronal apoptosis mediated by LPS stimulated BV2 microglial activation","volume":"37","author":"Kaewmool","year":"2020","journal-title":"Neurotoxic Res"},{"key":"B190","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.phymed.2018.03.039","article-title":"G protein coupled estrogen receptor is involved in the anti inflammatory effects of genistein in microglia","volume":"43","author":"Du","year":"2018","journal-title":"Phytomedicine"},{"key":"B191","doi-asserted-by":"publisher","DOI":"10.3390\/molecules28155837","article-title":"Icaritin promotes myelination by simultaneously enhancing the proliferation and differentiation of oligodendrocyte precursor cells","volume":"28","author":"Yang","year":"2023","journal-title":"Molecules"},{"key":"B192","doi-asserted-by":"publisher","DOI":"10.1212\/nxi.0000000000001142","article-title":"Baicalin promotes CNS remyelination via PPAR\u03b3 signal pathway","volume":"9","author":"Ai","year":"2022","journal-title":"Neurol Neuroimmunology Neuroinflamm"},{"key":"B193","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2025.1659631","article-title":"Baicalein improves motor dysfunction and cognitive impairment while promoting remyelination in an animal model of multiple sclerosis through the antioxidant mechanism","volume":"16","author":"Wang","year":"2025","journal-title":"Front Pharmacol"},{"key":"B194","doi-asserted-by":"publisher","DOI":"10.3390\/antiox14060723","article-title":"Scutellarin alleviates cuprizone induced demyelination by improving mitochondrial dysfunction, reducing lipid oxidation and inhibiting the p38 MAPK pathway","volume":"14","author":"Zhao","year":"2025","journal-title":"Antioxidants"},{"key":"B195","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2020.00992","article-title":"Natural products impacting DNA methyltransferases and histone deacetylases","volume":"11","author":"Akone","year":"2020","journal-title":"Front Pharmacol"},{"key":"B196","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/j.brainresbull.2021.07.010","article-title":"Icariin ameliorates the cuprizone induced acute brain demyelination and cognitive deficits in mice","volume":"173","author":"Cong","year":"2021","journal-title":"Brain Res Bull"},{"key":"B197","doi-asserted-by":"publisher","DOI":"10.7554\/elife.44667","article-title":"Astrocyte morphogenesis is dependent on BDNF signaling via astrocytic TrkB.T1","volume":"8","author":"Holt","year":"2019","journal-title":"eLife"},{"key":"B198","doi-asserted-by":"publisher","first-page":"102357","DOI":"10.1016\/j.neures.2023.02.001","article-title":"Astrocytes and brain derived neurotrophic factor","volume":"226","author":"Albini","year":"2023","journal-title":"Prog Neurobiol"},{"key":"B199","doi-asserted-by":"publisher","first-page":"10894","DOI":"10.1038\/s41598-021-97908-x","article-title":"Protective mechanism of Erigeron breviscapus injection on the blood brain barrier after ischemic stroke in rat","volume":"11","author":"Liu","year":"2021","journal-title":"Sci Rep"},{"key":"B200","doi-asserted-by":"publisher","DOI":"10.1248\/bpb.b21-00408","article-title":"Claudin 5: A pharmacological target to modify the permeability of the blood brain barrier","volume":"44","author":"Hashimoto","year":"2021","journal-title":"Biol Pharm Bull"},{"key":"B201","doi-asserted-by":"publisher","first-page":"147586","DOI":"10.1016\/j.brainres.2021.147626","article-title":"Baicalein ameliorates ischemic brain damage through suppressing pro inflammatory microglial mediators and enhancing TGF \u03b2","volume":"1769","author":"Ran","year":"2021","journal-title":"Brain Res"},{"key":"B202","doi-asserted-by":"publisher","first-page":"112755","DOI":"10.1016\/j.celrep.2023.112889","article-title":"IGFBPL1 is a master driver of microglia homeostasis and resolution of neuroinflammation via IGF 1 receptor signaling","volume":"42","author":"Pan","year":"2023","journal-title":"Cell Rep"},{"key":"B203","doi-asserted-by":"publisher","first-page":"365","DOI":"10.3389\/fnagi.2017.00365","article-title":"Insulin like growth factor 1 and neuroinflammation","volume":"9","author":"Carro","year":"2017","journal-title":"Front Aging Neurosci"},{"key":"B204","doi-asserted-by":"publisher","first-page":"7639","DOI":"10.3390\/molecules28227639","article-title":"Vitexin regulates heat shock protein expression by modulating reactive oxygen species levels","volume":"28","author":"Wu","year":"2023","journal-title":"Molecules"},{"key":"B205","doi-asserted-by":"publisher","first-page":"234","DOI":"10.3389\/fncel.2019.00234","article-title":"Axonal spectrins: Nanoscale organization, functional domains, and spectrinopathy","volume":"13","author":"Lorenzo","year":"2019","journal-title":"Front Cell Neurosci"},{"key":"B206","doi-asserted-by":"publisher","DOI":"10.1126\/science.adn6712","article-title":"The membrane skeleton is constitutively remodeled in neurons through calcium signaling and calpain mediated spectrin degradation","volume":"386","author":"Heller","year":"2024","journal-title":"Science"},{"key":"B207","doi-asserted-by":"publisher","first-page":"114262","DOI":"10.1016\/j.biopha.2023.114240","article-title":"Brain targeted borneol baicalin liposome improves blood brain barrier penetration and anti inflammatory effects","volume":"158","author":"Long","year":"2023","journal-title":"Biomedicine Pharmacotherapy"},{"key":"B208","doi-asserted-by":"publisher","DOI":"10.1007\/s13346-021-00917-6","article-title":"Quercetin biapigenin nanoparticles are effective to penetrate the blood brain barrier and protect brain cell lines from oxidative stress","volume":"11","author":"Oliveira","year":"2021","journal-title":"Drug Delivery Trans Res"},{"key":"B209","doi-asserted-by":"publisher","first-page":"989602","DOI":"10.3389\/fbioe.2022.989602","article-title":"Epigallocatechin 3 gallate selenium nanoparticles for neuroprotection after spinal cord injury","volume":"10","author":"Wang","year":"2022","journal-title":"Front Bioeng Biotechnol"},{"key":"B210","doi-asserted-by":"publisher","first-page":"566","DOI":"10.1016\/j.devcel.2017.03.001","article-title":"miR 219 cooperates with miR 338 in myelination and promotes myelin repair","volume":"40","author":"Wang","year":"2017","journal-title":"Dev Cell"},{"key":"B211","doi-asserted-by":"publisher","first-page":"46","DOI":"10.3389\/fgene.2012.00046","article-title":"Regulation of miRNA 219 and miRNA clusters 338 and 17 92 in oligodendrocytes in vivo and in vitro","volume":"3","author":"de Faria","year":"2012","journal-title":"Front Genet"},{"key":"B212","doi-asserted-by":"publisher","first-page":"3263446","DOI":"10.1155\/2022\/3263446","article-title":"Baicalin mitigates neuroinflammation through the TLR4 MyD88 NF kappa B and MAPK pathways and inhibits miR 155 in BV 2 microglia","volume":"2022","author":"Zhou","year":"2022","journal-title":"BioMed Res Int"},{"key":"B213","doi-asserted-by":"publisher","first-page":"636172","DOI":"10.3389\/fnins.2021.636172","article-title":"Quercetin attenuates diabetic peripheral neuropathy by correcting mitochondrial dysfunction via AMPK PGC 1\u03b1 signaling","volume":"15","author":"Zhang","year":"2021","journal-title":"Front Neurosci"},{"key":"B214","doi-asserted-by":"publisher","first-page":"1224964","DOI":"10.3389\/fnmol.2023.1224964","article-title":"Mechanism of PGC 1\u03b1 mediated mitochondrial biogenesis in cerebral ischemia","volume":"16","author":"Yuan","year":"2023","journal-title":"Front Mol Neurosci"},{"key":"B215","doi-asserted-by":"publisher","DOI":"10.1002\/jbt.22800","article-title":"Antioxidative effects of silymarin on the reduction of liver complications of fingolimod in patients with relapsing remitting multiple sclerosis: A clinical trial study","volume":"35","author":"Ghiasian","year":"2021","journal-title":"J Biochem Toxicol"},{"key":"B216","doi-asserted-by":"publisher","DOI":"10.1002\/ptr.7050","article-title":"A systematic review of possible interactions for herbal medicines and dietary supplements used concomitantly with disease\u2010modifying or symptom\u2010alleviating multiple sclerosis drugs","volume":"35","author":"Petersen","year":"2021","journal-title":"Phytother Res"},{"key":"B217","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics14122732","article-title":"New and old horizons for an ancient drug: Pharmacokinetics, pharmacodynamics, and clinical perspectives of dimethyl fumarate","volume":"14","author":"Matteo","year":"2022","journal-title":"Pharmaceutics"},{"key":"B218","doi-asserted-by":"publisher","DOI":"10.3390\/antiox9090865","article-title":"Epigenetic regulation of NRF2 KEAP1 by phytochemicals","volume":"9","author":"Bhattacharjee","year":"2020","journal-title":"Antioxidants"},{"key":"B219","doi-asserted-by":"publisher","DOI":"10.3390\/antiox10121859","article-title":"Bioactive compounds in oxidative stress mediated diseases: Targeting the NRF2 ARE signaling pathway and epigenetic regulation","volume":"10","author":"Thiruvengadam","year":"2021","journal-title":"Antioxidants"},{"key":"B220","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2023.1264842","article-title":"Novel potential pharmacological applications of dimethyl fumarate\u2014an overview and update","volume":"14","author":"Bresciani","year":"2023","journal-title":"Front Pharmacol"},{"key":"B221","doi-asserted-by":"publisher","DOI":"10.1007\/s11101-014-9358-0","article-title":"Flavonoid compounds as reversal agents of the P glycoprotein mediated multidrug resistance: Biology, chemistry and pharmacology","volume":"14","author":"Ferreira","year":"2015","journal-title":"Phytochem Rev"},{"key":"B222","doi-asserted-by":"publisher","first-page":"39","DOI":"10.2174\/2772432817666220412110720","article-title":"Safety and monitoring of the treatment with disease modifying therapies for multiple sclerosis","volume":"18","author":"Stamatellos","year":"2023","journal-title":"Curr Rev Clin Exp Pharmacol"},{"key":"B223","article-title":"Combining glatiramer acetate with epigallocatechin 3 gallate fails to further ameliorate chronic experimental autoimmune encephalomyelitis","volume":"278","author":"Millward","year":"2015","journal-title":"J Neuroimmunology"},{"key":"B224","doi-asserted-by":"publisher","DOI":"10.1212\/NXI.0000000000000981","article-title":"Epigallocatechin gallate in relapsing remitting multiple sclerosis: A randomized, placebo controlled phase II trial","volume":"27","author":"Bellmann Strobl","year":"2021","journal-title":"Multiple Sclerosis J"},{"key":"B225","doi-asserted-by":"publisher","DOI":"10.3945\/ajcn.113.075309","article-title":"Metabolic response to epigallocatechin-3-gallate in relapsing-remitting multiple sclerosis: a randomized clinical trial","volume":"101","author":"M\u00e4hler","year":"2015","journal-title":"Am J Clin Nutr"},{"key":"B226","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1186\/1742-2094-6-28","article-title":"Luteolin and interferon \u03b2 synergistically suppress inflammatory responses in multiple sclerosis patient derived immune cells","volume":"207","author":"Sternberg","year":"2009","journal-title":"J Neuroimmunology"},{"key":"B227","doi-asserted-by":"publisher","DOI":"10.1016\/j.mayocp.2013.11.002","article-title":"Multiple sclerosis: Current and emerging disease modifying therapies and treatment strategies","volume":"89","author":"Wingerchuk","year":"2014","journal-title":"Mayo Clinic Proc"},{"key":"B228","doi-asserted-by":"publisher","DOI":"10.1007\/s40263-022-00965-7","article-title":"High efficacy therapies for treatment na\u00efve individuals with relapsing remitting multiple sclerosis","volume":"36","author":"Freeman","year":"2022","journal-title":"CNS Drugs"},{"key":"B229","doi-asserted-by":"publisher","DOI":"10.1016\/j.bcp.2022.115257","article-title":"Flavonoids bridging the gut and the brain: Intestinal metabolic fate, and direct or indirect effects of natural supporters against neuroinflammation and neurodegeneration","volume":"205","author":"Magni","year":"2022","journal-title":"Biochem Pharmacol"},{"key":"B230","doi-asserted-by":"publisher","first-page":"108771","DOI":"10.2139\/ssrn.3628295","article-title":"PhosR enables processing and functional analysis of phosphoproteomic data","volume":"36","author":"Kim","year":"2021","journal-title":"Cell Rep"},{"key":"B231","doi-asserted-by":"publisher","DOI":"10.3390\/ijms11041321","article-title":"Bioavailability of the polyphenols: Status and controversies","volume":"11","author":"D\u2019Archivio","year":"2010","journal-title":"Int J Mol Sci"},{"key":"B232","article-title":"Generally recognized as safe GRAS","year":"2023"},{"key":"B233","doi-asserted-by":"publisher","DOI":"10.1016\/j.freeradbiomed.2004.08.002","article-title":"Flavonoids and the brain: Interactions at the blood brain barrier and their physiological effects on the central nervous system","volume":"37","author":"Youdim","year":"2004","journal-title":"Free Radical Biol Med"},{"key":"B234","article-title":"Clinical drug interaction studies cytochrome P450 enzyme and transporter mediated drug interactions: Guidance for industry","year":"2020"},{"key":"B235","doi-asserted-by":"publisher","first-page":"18","DOI":"10.2147\/dddt.s447496","article-title":"Advances in nanotechnology for enhancing the solubility and bioavailability of poorly soluble drugs","author":"Liu","year":"2024","journal-title":"Drug Des Dev Ther"},{"key":"B236","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1186\/s12906-024-04587-y","article-title":"Medicinal plants used in multiple sclerosis patients: Prevalence and associated factors","volume":"24","author":"Nikvarz","year":"2024","journal-title":"BMC Complementary Med Ther"},{"key":"B237","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-019-0903-2","article-title":"Altered human oligodendrocyte heterogeneity in multiple sclerosis","volume":"566","author":"J\u00e4kel","year":"2019","journal-title":"Nature"},{"key":"B238","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuron.2024.11.016","article-title":"snRNA seq stratifies multiple sclerosis patients into distinct white matter glial programs","volume":"113","author":"Macnair","year":"2024","journal-title":"Neuron"},{"key":"B239","doi-asserted-by":"publisher","DOI":"10.1038\/s41593-024-01796-z","article-title":"Cell type mapping reveals tissue niches and interactions in subcortical multiple sclerosis lesions","volume":"27","author":"Lerma Martin","year":"2024","journal-title":"Nat Neurosci"},{"key":"B240","doi-asserted-by":"publisher","DOI":"10.1038\/s41593-024-01765-6","article-title":"Spatially resolved gene signatures of white matter lesion progression in multiple sclerosis","volume":"27","author":"Chen","year":"2024","journal-title":"Nat Neurosci"},{"key":"B241","doi-asserted-by":"publisher","DOI":"10.1038\/nature19949","article-title":"Mass spectrometric exploration of proteome structure and function","volume":"537","author":"Aebersold","year":"2016","journal-title":"Nature"},{"key":"B242","doi-asserted-by":"publisher","first-page":"100800","DOI":"10.1016\/j.mcpro.2024.100800","article-title":"Data independent acquisition: A milestone and prospect in clinical mass spectrometry based proteomics","volume":"23","author":"Fr\u00f6hlich","year":"2024","journal-title":"Mol Cell Proteomics"},{"key":"B243","doi-asserted-by":"publisher","first-page":"564446","DOI":"10.3389\/fnmol.2020.564446","article-title":"Recent developments in data independent acquisition mass spectrometry: Application to neuroproteomics","volume":"13","author":"Smit","year":"2020","journal-title":"Front Mol Neurosci"},{"key":"B244","doi-asserted-by":"publisher","DOI":"10.1021\/acsmeasuresciau.4c00007","article-title":"A tutorial review of labeling methods in MS based proteomics","volume":"4","author":"Chatterjee","year":"2024","journal-title":"ACS Measurement Sci Au"},{"key":"B245","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1016\/j.jconrel.2016.05.044","article-title":"Nanoparticle mediated brain drug delivery: Overcoming blood brain barrier to treat neurodegenerative diseases","volume":"235","author":"Saraiva","year":"2016","journal-title":"J Controlled Release"},{"key":"B246","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejps.2020.105314","article-title":"Quercetin lipid nanoparticles functionalized with transferrin for Alzheimer\u2019s disease","volume":"148","author":"Pinheiro","year":"2020","journal-title":"Eur J Pharm Sci"},{"key":"B247","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1007\/s11095-020-02865-1","article-title":"RVG29 functionalized lipid nanoparticles for quercetin brain delivery and Alzheimer\u2019s disease","volume":"37","author":"Pinheiro","year":"2020","journal-title":"Pharm Res"},{"key":"B248","article-title":"Nanomaterials for drug delivery to the brain: Targeting strategies and responsive systems","volume":"183","author":"Teleanu","year":"2021","journal-title":"Int J Biol Macromol"},{"key":"B249","doi-asserted-by":"publisher","DOI":"10.1038\/s41573-023-00774-7","article-title":"Artificial intelligence for natural product drug discovery","volume":"22","author":"Mullowney","year":"2023","journal-title":"Nat Rev Drug Discov"},{"key":"B250","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gkac382","article-title":"SynergyFinder 3.0: An interactive platform for multi drug combination profiling with deep learning based synergy scoring","volume":"50","author":"Ianevski","year":"2022","journal-title":"Nucleic Acids Res"},{"key":"B251","doi-asserted-by":"publisher","DOI":"10.1007\/s10462-023-10669-z","article-title":"Graph neural networks for predicting synergistic drug combinations: A review","volume":"56","author":"Koirala","year":"2023","journal-title":"Artif Intell Rev"},{"key":"B252","doi-asserted-by":"publisher","DOI":"10.1093\/bioinformatics\/btad438","article-title":"DeepTraSynergy: Drug combinations using multimodal deep learning with transformers","volume":"39","author":"Zhang","year":"2023","journal-title":"Bioinformatics"},{"key":"B253","doi-asserted-by":"publisher","first-page":"14321","DOI":"10.1038\/s41598-024-66897-y","article-title":"Predicting blood brain barrier permeability using large language models and molecular descriptors","volume":"14","author":"Alqahtani","year":"2024","journal-title":"Sci Rep"},{"key":"B254","article-title":"Tea polyphenol epigallocatechin 3 gallate inhibits DNA methyltransferase and reactivates methylation silenced genes in cancer cells","volume":"63","author":"Fang","year":"2003","journal-title":"Cancer Res"},{"key":"B255","doi-asserted-by":"publisher","first-page":"121085","DOI":"10.1016\/j.bioorg.2024.107652","article-title":"Targeting DNA methyltransferases for cancer therapy: Mechanisms, challenges and opportunities","volume":"339","author":"Khan","year":"2024","journal-title":"Life Sci"},{"key":"B256","doi-asserted-by":"publisher","first-page":"63","DOI":"10.3390\/molecules25010063","article-title":"Quercetin, epigallocatechin 3 gallate, curcumin and resveratrol: From dietary sources to human microRNA modulation","volume":"25","author":"Scicchitano","year":"2020","journal-title":"Molecules"},{"key":"B257","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms12015","article-title":"Alterations of the human gut microbiome in multiple sclerosis","volume":"7","author":"Jangi","year":"2016","journal-title":"Nat Commun"},{"key":"B258","doi-asserted-by":"publisher","first-page":"3467","DOI":"10.1016\/j.cell.2022.08.021","article-title":"Gut microbiome of multiple sclerosis patients and paired household healthy controls reveal associations with disease risk and course","volume":"185","year":"2022","journal-title":"Cell"},{"key":"B259","doi-asserted-by":"publisher","DOI":"10.1021\/acssynbio.4c00383","article-title":"Advances in flavonoid and derivative biosynthesis: Systematic strategies for the construction of yeast cell factories","volume":"13","author":"Wang","year":"2024","journal-title":"ACS Synth Biol"},{"key":"B260","doi-asserted-by":"publisher","DOI":"10.3389\/fceng.2022.880694","article-title":"Plant flavonoid production in bacteria and yeasts","volume":"4","author":"Isogai","year":"2022","journal-title":"Front Chem Eng"},{"key":"B261","doi-asserted-by":"publisher","DOI":"10.1016\/b978-012551570-2\/50007-0","article-title":"Engineering Escherichia coli toward de novo production of gatekeeper flavanones","volume":"5","author":"Jones","year":"2020","journal-title":"Synth Biol"},{"key":"B262","doi-asserted-by":"publisher","DOI":"10.1038\/nbt.4222","article-title":"Development of a synthetic live bacterial therapeutic for the human metabolic disease phenylketonuria","volume":"36","author":"Isabella","year":"2018","journal-title":"Nat Biotechnol"},{"key":"B263","doi-asserted-by":"publisher","DOI":"10.1016\/j.tips.2022.02.002","article-title":"Emerging strategies for engineering Escherichia coli Nissle 1917 based living therapeutics","volume":"43","author":"Riglar","year":"2022","journal-title":"Trends Pharmacol Sci"},{"key":"B264","doi-asserted-by":"publisher","first-page":"1000873","DOI":"10.3389\/fbioe.2022.1000873","article-title":"Microbiome engineering: Engineered live biotherapeutic products for precision medicine","volume":"10","author":"Mays","year":"2022","journal-title":"Front Bioeng Biotechnol"},{"key":"B265","doi-asserted-by":"publisher","DOI":"10.1021\/acssynbio.4c00036","article-title":"Engineering a probiotic toolkit in Escherichia coli Nissle 1917 for inflammation responsive therapeutic delivery","volume":"13","author":"Dinh","year":"2024","journal-title":"ACS Synth Biol"},{"key":"B266","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pcbi.1010980","article-title":"Multiscale networks in multiple sclerosis","volume":"19","author":"Pappalardo","year":"2023","journal-title":"PloS Comput Biol"},{"key":"B267","doi-asserted-by":"publisher","DOI":"10.1016\/j.molmed.2020.04.006","article-title":"Multi tissue multi omics systems biology to dissect complex diseases","volume":"26","author":"Hasin","year":"2020","journal-title":"Trends Mol Med"},{"key":"B268","doi-asserted-by":"publisher","DOI":"10.1038\/nbt.2989","article-title":"Microfluidic organs on chips","volume":"32","author":"Bhatia","year":"2014","journal-title":"Nat Biotechnol"},{"key":"B269","doi-asserted-by":"publisher","DOI":"10.3389\/fnmol.2023.1250123","article-title":"Human BBB on a chip reveals barrier disruption, endothelial inflammation, and T cell migration under neuroinflammatory conditions","volume":"16","author":"Nair","year":"2023","journal-title":"Front Mol Neurosci"},{"key":"B270","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1186\/s12987-023-00490-9","article-title":"Microfluidic models of the neurovascular unit: A translational view","volume":"20","author":"Wevers","year":"2023","journal-title":"Fluids Barriers CNS"},{"key":"B271","doi-asserted-by":"publisher","first-page":"995","DOI":"10.1016\/j.stem.2019.05.011","article-title":"Human iPSC derived blood brain barrier chips enable disease modeling and personalized medicine applications","volume":"24","author":"Vatine","year":"2019","journal-title":"Cell Stem Cell"},{"key":"B272","doi-asserted-by":"publisher","DOI":"10.1016\/j.molmed.2010.11.006","article-title":"EAE: Imperfect but useful models of multiple sclerosis","volume":"17","author":"t Hart","year":"2011","journal-title":"Trends Mol Med"},{"key":"B273","doi-asserted-by":"publisher","DOI":"10.1007\/s00401-016-1631-4","article-title":"Multiple sclerosis: Experimental models and reality","volume":"133","author":"Lassmann","year":"2017","journal-title":"Acta Neuropathol"},{"key":"B274","doi-asserted-by":"publisher","DOI":"10.14670\/HH-26.1585","article-title":"De and remyelination in the CNS white and grey matter induced by cuprizone: The old, the new, and the unexpected","volume":"26","author":"Skripuletz","year":"2011","journal-title":"Histol Histopathol"},{"key":"B275","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0130251","article-title":"Treatment of chronic experimental autoimmune encephalomyelitis with epigallocatechin 3 gallate and glatiramer acetate alters expression of heme oxygenase 1","volume":"10","author":"Janssen","year":"2015","journal-title":"PloS One"},{"key":"B276","doi-asserted-by":"publisher","DOI":"10.1177\/00912700122010366","article-title":"Pharmacokinetics and bioavailability of quercetin glycosides in humans","volume":"41","author":"Graefe","year":"2001","journal-title":"J Clin Pharmacol"},{"key":"B277","doi-asserted-by":"publisher","DOI":"10.1079\/bjn20061809","article-title":"Absorption, excretion and metabolite profiling of methyl, glucuronyl, glucosyl and sulpho conjugates of quercetin in human plasma and urine after ingestion of onions","volume":"96","author":"Mullen","year":"2006","journal-title":"Br J Nutr"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2026.1888423\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T09:01:35Z","timestamp":1785402095000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2026.1888423\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,30]]},"references-count":277,"alternative-id":["10.3389\/fimmu.2026.1888423"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2026.1888423","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,30]]},"article-number":"1888423"}}